ClinicalTrials.gg
RecruitingNCT07099963Updated Nov 5, 2026

Frequency and Severity of Respiratory Acidosis During One-lung Ventilation, a Retrospective Pilot Study to Compare Clinician Settings and Those Proposed by the VentilO Application

An observational study in Thoracic, Surgery and Mechanical Ventilation, sponsored by Laval University. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Laval University · Observational

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.
Updated Nov 5, 2026Primary completion movedStudy completion movedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

One-lung ventilation is a mechanical ventilation method frequently used during several thoracic surgeries. One-lung ventilation requires the use of protective ventilation to limit ventilator-induced injury and reduce postoperative respiratory complications. Protective ventilation during one-lung ventilation is specific since tidal volumes are applied by definition to one lung, and it is recommended to use lower tidal volumes, down to 4 ml/kg of ideal body weight. This approach requires individualized ventilation parameters, which differs from the conventional or two-lung ventilation, and there are no clear recommendations regarding respiratory rate adjustment to ensure adequate gas exchange.

Read the detailed description

The aim of the study is to:

  1. Evaluate whether the initial ventilation settings (tidal volume and respiratory rate) during one-lung ventilation are appropriate to prevent respiratory acidosis.
  2. Compare the ventilation settings (tidal volume and respiratory rate) made by clinicians with those proposed by an smartphone application ''VentilO''.
02

Conditions studied

  • Thoracic
  • Surgery
  • Mechanical Ventilation
  • Hypercapnia
  • Acidosis
  • One Lung Ventillation (OLV)
  • Smartphone Application
03

In context

Hypercapnia

156 studies on the registry are indexed under Hypercapnia; 31 are open to participants now.

This study's planned enrollment of 100 is above the median of 60 across 31 observational studies indexed under Hypercapnia.

Browse Hypercapnia studies →

Lead sponsor

Laval University is the lead sponsor of 380 studies on the registry; 67 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patient undergoing thoracic surgery requiring intraoperative one-lung ventilation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (≥ 18 years old)
  • Patients intubated and undergoing one-lung ventilation during thoracic surgery
  • Volume-controlled ventilation mode used intraoperatively

Exclusion criteria

Exclusion Criteria:

  • Arterial blood gas data unavailable during one-lung ventilation
  • Missing demographic data (sex, height, actual weight)
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Thoracic surgery

    Patient managed with one lung ventilation

    Other: one lung ventilation

Interventions

  • Otherone lung ventilation

    Arterial blood gases during one lung ventilation

06

What researchers measure

Primary outcomes

  1. Respiratory acidosis

    The frequency of respiratory acidosis on arterial blood gases after 20 minutes of mechanical ventilation (pH \< 7.35 and PaCO2 \> 45mmHg) measured by arterial blood gases

    Time frame: 20 minutes after initiation of one lung ventilation after lung isolation

Secondary outcomes

  1. Respiratory rate

    Respiratory rate set by the doctor, this respiratory rate will be compared to the suggestion of the algorithm

    Time frame: At the beginning of one lung ventilation during the surgery

  2. Acid-base disorder

    Presence of Respiratory alkalosis define by pH\>7.45 and PaCO2 \< 35 mmHg

    Time frame: At the beginning of one lung ventilation during the surgery

  3. Number of participants with hemodynamic shock - hypotension

    Requiring \>1L of volume repletion and/or use of amines at \>0.05 mcg/kg/min or norepinephrine equivalent

    Time frame: Day 1

  4. Hospital length of stay

    Recovery room admission through hospital discharge

    Time frame: Up to 90 days

  5. Mechanical Ventilation duration

    Time spent with invasive mechanical ventilation during surgery and hospital stay

    Time frame: Up to 90 days

  6. Hospital mortality

    Occurence of death during hospital stay

    Time frame: Up to 90 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Primary completion
Dec 2025→Mar 1, 2026 (actual)
Nov 5, 2026
Study completion
Jun 2026→Jun 2027
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Primary completion Dec 2025→Mar 1, 2026 (now actual)
    Study completion Jun 2026→Jun 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07099963
Lead sponsor
Laval University
Responsible party
François Lellouche (Principal Investigator, Laval University) — Principal investigator
First posted
Aug 1, 2025
Start date
Aug 1, 2025
Primary completion
Mar 1, 2026
Completion
Jun 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Francois Lellouche
Contact
francois.lellouche@criucpq.ulaval.ca
1-418-656-8711

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion